CD8A and neoplasm: RMS tumors typically exhibit an “immune-cold” phenotype, characterized by a low tumor mutational burden (TMB), decreased neoantigen presentation, and limited infiltration of effector immune cells, such as cytotoxic CD8+ T lymphocytes [18].